Parkinson's disease effect on autonomic modulation: an analysis using geometric indices

Parkinson's disease effect on autonomic modulation: an analysis using geometric indices

ABSTRACT Background: Parkinson's disease (PD) produces autonomic changes, indicating lower parasympathetic modulation and global variability, but these changes need further studying regarding geometric methods. Objective: To investigate the autonomic modulation in individuals with PD using he...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mileide Cristina Stoco-Oliveira, Ana Laura Ricci-Vitor, Laís Manata Vanzella, Heloisa Balotari Valente, Vitor Eduardo dos Santos Silva, Larissa Borba André, Augusto Cesinando de Carvalho, David Matthew Garner, Luiz Carlos Marques Vanderlei
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações 2021-03-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	Parkinson Disease Autonomic Nervous System Primary Dysautonomias Neurodegenerative Diseases
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2021000200114&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Does length of time since diagnosis in Parkinson’s disease influence heart rate variability? A cross-sectional study
by: Mileide Cristina Stoco-Oliveira, et al.
Published: (2022-05-01)

Autonomic and cardiorespiratory responses to the active tilt test in individuals with Parkinson disease: cross-sectional study
by: Heloisa Balotari Valente, et al.
Published: (2022-07-01)

Autonomic modulation at rest and in response to postural change in adolescents with Duchenne muscular dystrophy: a cross-sectional study
by: Mariana Viana Rodrigues, et al.
Published: (2021-10-01)

Comparative study of autonomic dysfunction between Parkinson’s disease with LRRK2, PRKN, and GBA mutations
by: Bárbara Maldotti Dalla Corte, et al.
Published: (2025-08-01)

Sex-differences in autonomic and cardiovascular responses to multimodal therapy in Parkinson’s disease: a pilot study
by: Franziska Siche-Pantel, et al.
Published: (2025-06-01)

Intact microdissection of stellate ganglia in a Parkinson's disease model reveals aggregation of mutant human α‐synuclein in their cell bodies
by: Bonn Lee, et al.
Published: (2025-06-01)

When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson’s disease?
by: De Luka Silvio R., et al.
Published: (2014-01-01)

Long‐Term POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
by: Jeffrey R. Boris, et al.
Published: (2024-07-01)

EVALUATION OF SWALLOWING AND NUTRITION STATUS IN PARKINSON’S DISEASE
by: Erdi Şahin, et al.
Published: (2025-03-01)

Identification of nitric oxide-mediated necroptosis as the predominant death route in Parkinson’s disease
by: Ting Zhang, et al.
Published: (2024-10-01)

Walking detection for Parkinson’s disease patients and healthy control subjects measured with a smartphone accelerometer using mean amplitude deviation algorithm
by: Milla Juutinen, et al.
Published: (2025-05-01)

Adherence to a Mediterranean Diet and Risks of Alzheimer and Parkinson Diseases: A Systematic Review of Population-Based Studies
by: Sukshma Sharma, et al.
Published: (2023-11-01)

Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer’s Disease and Parkinson’s Disease
by: Jung YH, et al.
Published: (2025-04-01)

Frequency of orthostatic hypotension in the Pooled Resource Open-Access ALS Clinical Trials database
by: C. Quarracino, et al.
Published: (2025-01-01)

Applying Wearable Sensors and Machine Learning to the Diagnostic Challenge of Distinguishing Parkinson’s Disease from Other Forms of Parkinsonism
by: Rana M. Khalil, et al.
Published: (2025-02-01)

Azotni oksid, neurodegeneracija i Parkinsonova bolest
by: Džoljić Eleonora, et al.
Published: (2005-01-01)

The genetic basis of Parkinson's disease
by: A. A. Tappakhov, et al.
Published: (2017-03-01)

The emerging role of disease-associated microglia in Parkinson’s disease
by: Ritika R. Samant, et al.
Published: (2024-11-01)

The Role of the Claustrum in Parkinson’s Disease and Vascular Parkinsonism: A Matter of Network?
by: Marialuisa Zedde, et al.
Published: (2025-01-01)

Prevalence, distribution and future projections of Parkinson disease in Brazil: insights from the ELSI-Brazil cohort studyResearch in context
by: Thomas Hugentobler Schlickmann, et al.
Published: (2025-04-01)

Role of metabolic characteristics in the co-occurrence of insomnia, Alzheimer’s disease, and Parkinson’s disease: a Mendelian randomization study
by: Chengyong Liu, et al.
Published: (2025-01-01)

Comparison of Dysautonomia Across Species: Current Knowledge and Future Research Opportunities
by: Callum N. Atkins, et al.
Published: (2025-07-01)

Assessment of causality association between serum adiponectin levels and the risk of Alzheimer’s disease and Parkinson’s disease: a Mendelian randomization study
by: Jiali Lin, et al.
Published: (2025-04-01)

Association between oral dysbiosis and Parkinson’s disease: a systematic review
by: Laura Murcia-Flores, et al.
Published: (2025-05-01)

Guidelines for Parkinson's disease management part II: consensus from the movement disorders scientific department of the Brazilian Academy of Neurology – non-motor symptoms
by: Débora Palma Maia, et al.
Published: (2025-01-01)

Botulinum toxin in the treatment of sialorrhea
by: Svetel Marina, et al.
Published: (2009-01-01)

Galvanic vestibular stimulation to rehabilitate postural instability in Parkinson's disease
by: Anna Paula Batista de Ávila Pires, et al.
Published: (2025-03-01)

The Modified Functional Status Questionnaire for Assessing Patients with Parkinson’s Disease Psychosis Treated with Pimavanserin: A Post Hoc Analysis
by: Virgilio G. H. Evidente, et al.
Published: (2025-05-01)

Impact of rapid eye movement sleep behavior disorder and autonomic disorders on Parkinson's disease: a review
by: Pérola de Oliveira, et al.
Published: (2021-03-01)

Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
by: Nidhi Puranik, et al.
Published: (2025-02-01)

Retinal optical coherence tomography changes as biomarkers for Parkinsonism duration and severity in the Kashmiri population
by: Irtiqa Mohammad, et al.
Published: (2024-12-01)

Neuroprotective effect of cedrol in a male rat model of Parkinson's disease
by: Fatemeh Forouzanfar, et al.
Published: (2025-04-01)

Autonomic thermoregulatory dysfunction in neurofibromatosis type 1
by: Luciana G Madeira, et al.

Recent advances in targeting LRRK2 for Parkinson’s disease treatment
by: Mahsa Karami, et al.
Published: (2025-07-01)

Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases
by: Eleftheria-Emmanouela Katsoulaki, et al.
Published: (2025-06-01)

Reimagining Day Rehabilitation For Frailty and Neurodegenerative Conditions through the integrated Rehabilitation and EnAblement Program (iREAP)
by: Genevieve Maiden, et al.
Published: (2024-09-01)

Parkinson's Disease Database in the Middle East, North Africa, and South Asia Countries
by: Hanan Khalil, et al.
Published: (2025-06-01)

Does Parkinson's disease start in the gut?
by: Oscar S. Gershanik

A bibliometric analysis of acupuncture treatment and cognitive impairment
by: Xiaoqi Yu, et al.
Published: (2025-06-01)

VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration
by: Shirel Argueti-Ostrovsky, et al.
Published: (2024-12-01)